Share this post on:

Name :
KBTBD2 antibody

Documents :
DataSheet Material Safety Data Sheets (MSDS)

Description :
KBTBD2 Rabbit Polyclonal antibody. Positive WB detected in COLO 320 cells. Positive IHC detected in human colon cancer tissue.

Tested applications :
ELISA, IHC, WB

Species reactivity :
Human,Mouse,Rat; other species not tested.

Alternative names :
BKLHD1 antibody; KBTBD2 antibody; KIAA1489 antibody

Immunogen :

Isotype :
Rabbit IgG

Preparation :
This antibody was obtained by immunization of KBTBD2 recombinant protein (Accession Number: NM_015483). Purification method: Antigen affinity purified.

Clonality :
Polyclonal

Formulation :
PBS with 0.02% sodium azide and 50% glycerol pH 7.3.

Storage instructions :
Store at -20℃. DO NOT ALIQUOT

Applications :
Recommended Dilution: WB: 1:200-1:2000IHC: 1:20-1:200

Background :
KBTBD2 represents kelch repeat and BTB (POZ) domain containing 2

References :

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
c-Kit Antibody
Trontinemab
CXCL9 Antibody: CXCL9 Antibody is an unconjugated, approximately 14 kDa, rabbit-derived, anti-CXCL9 polyclonal antibody. CXCL9 Antibody can be used for: ELISA, IHC-P, IHC-F, IF expriments in human, mouse, and predicted: rat, pig, cow, horse background without labeling.

Share this post on:

Author: Gardos- Channel